Cost-effectiveness analysis of somatostatin analogues in the treatment of acromegaly in Brazil

This study aims to compare economic and patient impacts of the treatment of acromegaly with two different somatostatin analogues (octreotide LAR and lanreotide SR) in Brazil. A cost-effectiveness analysis was carried out under the Brazilian Public Health Care System (SUS) perspective. A decision ana...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arquivos brasileiros de endocrinologia e metabologia 2008-12, Vol.52 (9), p.1452-1460
Hauptverfasser:	Valentim, Joice, Passos, Vanessa, Mataveli, Fabio, Calabró, Alessandra
Format:	Artikel
Sprache:	eng
Schlagworte:	Acromegaly - drug therapy Acromegaly - economics Antineoplastic Agents, Hormonal - economics Antineoplastic Agents, Hormonal - therapeutic use Brazil Cost-Benefit Analysis Delivery of Health Care - economics ENDOCRINOLOGY & METABOLISM Humans Octreotide - economics Octreotide - therapeutic use Peptides, Cyclic - economics Peptides, Cyclic - therapeutic use Practice Guidelines as Topic Sensitivity and Specificity Somatostatin - analogs & derivatives Somatostatin - economics Somatostatin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!